Views And Reviews Taking Stock Rammya Mathew: Let’s help people live successfully to the end of their lives BMJ 2019; 364 doi: https://doi.org/10.1136/bmj.l807 (Published 26 February 2019) Cite this as: BMJ 2019;364:l807 Article Related content Metrics Responses Peer review Related articles Research News GPs should consider offering statins to all patients aged over 75, researchers say Published: 01 February 2019; BMJ 364 doi:10.1136/bmj.l522 Letter Too much medicine: symptoms matter Published: 02 April 2019; BMJ 365 doi:10.1136/bmj.l1454 Letter Being over 75 isn’t the end of life Published: 04 April 2019; BMJ 365 doi:10.1136/bmj.l1455 Letter Empowering patients to make informed choices Published: 04 April 2019; BMJ 365 doi:10.1136/bmj.l1456 See more Prescribing parkrun: medicalising a walk in the park BMJ April 08, 2025, 389 r670; DOI: https://doi.org/10.1136/bmj.r670 GPs can prescribe tirzepatide to priority patient groups from June BMJ April 02, 2025, 389 r665; DOI: https://doi.org/10.1136/bmj.r665 Exercise referral rates for patients with risk of cardiovascular disease vary widely across England, study reports BMJ February 12, 2025, 388 r287; DOI: https://doi.org/10.1136/bmj.r287 Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog finds BMJ November 13, 2024, 387 q2518; DOI: https://doi.org/10.1136/bmj.q2518 Semaglutide’s CVD indication could cost US Medicare $145bn extra a year BMJ August 28, 2024, 386 q1878; DOI: https://doi.org/10.1136/bmj.q1878 Cited by... Being over 75 isnt the end of lifeFulltext PDF Empowering patients to make informed choicesFulltext PDF Too much medicine: symptoms matterFulltext PDF
